Archive: 02/04/2015

Marker may predict breast cancer response to tamoxifen

The presence of lower-than-normal amounts of the protein TGFBR2 was associated with breast cancer resistance to treatment with the antiestrogen therapeutic tamoxifen, according to a study published in Cancer Research, a journal ...

page 8 from 10